chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Five hours after receiving vaccine arm became sore and she had difficulty lifting her arm. She then developed joint pain in her left leg and a headache. Then developed joint pain in her hands. By the next day the arm pain had eased but minor joint pain and muscle aches continued. Three days after vaccination, the arm pain returned achiness in joints was throbbing . This is easing 18 days post vaccination but is not gone. The arm pain is gone. The most disturbing symptom occurred two weeks post vaccination. The patient began getting warm sensations in her right foot along the lateral side and occasionally in the heel. This does not hurt but is also persisting and is disturbing. She is uncertain if there is any relationship with her Crohn's disease.
Information has been received from a physician referring to a patient of unknown age and gender. The patient's pertinent medical history and drug allergies were not reported. On an unknown date the patient received a dose of RECOMBIVAX HB (lot#, dose, strength and route unknown) two days early (inappropriate schedule of vaccine administered). No adverse effect reported. Additional information has been effect.
Severe sinus headache; Coughing; This spontaneous case was reported by a consumer and describes the occurrence of SINUS HEADACHE (Severe sinus headache) and COUGH (Coughing) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PREDNISONE, PARACETAMOL (TYLENOL) and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SINUS HEADACHE (Severe sinus headache) and COUGH (Coughing). At the time of the report, SINUS HEADACHE (Severe sinus headache) and COUGH (Coughing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Tylenol and Benadryl.
This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. The patient's pertinent medical history and drug reactions or allergies were not reported. On 14-JUL-2016, the patient was vaccinated with improperly stored PROQUAD (lot # M010478, expiration date 01-SEP-2017, albumin status therapy type, dose and route of administration were not reported). Concomitant therapy was not reported. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
listnessness. Sleepiness. Fell asleep 2 hours after injection, could not be awaken for 20 hours.
Raised painful blotchy rash at injection site and extending down arm. Pain radiating into clavicle. Fever x 3 days.
Patient received an expired vaccine as a 1st dose; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine as a 1st dose) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine as a 1st dose). On 01-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine as a 1st dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.    No concomitant medications was reported. No treatment drug details was reported.
Information has been received from a health professional concerning a 44-month-old female who on 08-JUN-2004 was vaccinated SC in the right leg with a first dose of Varivax (Lot # 641710/04252N). Concomitant therapy that day included a first dose of MMR II (Lot # 644707/0040P) administered SC in the left leg. On 26-OCT-2006 the patient experienced breakthrough chickenpox. Subsequently, the patient recovered from chickenpox on 06-NOV-2006. Unspecified medical attention was sought. Additional information has been requested.
according to mom approx 48hr p/vax pt lt upper leg became red & swollen;pt was vomiting (seen in ER 5 days p/vax);dx w/bacterial infect;seen by family MD;hosp 9JAN98 to 11JAN98 given IV ATB & devel 3 blisters;disch 11JAN98;
Call from hosp ER; pt brought in w/febrile seizure; recovering well & no hospitalization required;
pt states he started feeling nauseas, developed a headache, and had diarrhea.  The next day he had fever, chills, body aches, he was shaking.  His headache was getting worse.  All symptoms were getting better except the headache.  He thought he was feeling better but when he woke up today 4/6/2021 he was SOB and diarrhea was back. Pt has taken Pepto Bismol for his symptoms and will probably need to go to the ER since he is having trouble breathing.   He feels like he has had such a bad reaction to this since he possibly has had the covid vax in the past 90 days.
Developed COVID-19; Developed COVID-19; This is a spontaneous report from a contactable consumer or other non-healthcare professional. A 78-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number not reported), via an unspecified route of administration on an unspecified date in Jan2021 (at the age of 78-years-old) as dose number unknown, single for COVID-19 immunisation. Medical history included allergies to dairy products. Concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested positive for COVID-19. On 27Aug2021, the patient had developed COVID-19. The event resulted in doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care visit. The patient underwent lab tests which included SARS-CoV-2 test Developed COVID-19 on 27Aug2021. Therapeutic measures taken as a result of developed COVID-19 included monoclonal antibodies. The outcome of the event was recovering.   The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
20 hours of fever, extreme chills, muscle pain, headache, nausea.  Better the next day, but was hell during.
pt recv vax in AM approx 2 hr p/vax pt started to cry & pt had not stopped when returned back to clinic several hr later; can use APAP q 4 hr PRN; DPH given;
Sitting in post administration area under observation following vaccination. Patient reported tight feeling throat initially. Took BP 122/76 P=68.  Patient not anxious.  Watched for 5 more minutes and patient indicated that she was feeling tingling climbing up side of her neck toward jaw.  At that point, I instructed nursing student to administer one epipen at 12:48. Her tight throat and symptoms resolved but her pulse increased to 99 and her blood pressure went up to 144 /82 at 12:57 following the epinephrine injection. We continued to take her BP and called 911.  Ambulance picked her up at 1:20 PM and transported to Emergency Department. She was stable but needed evaluation for further treatment. RN Faculty on site during event.
started with a stomach ache then general aches throughout the torso. Turned pale, and shaky with a severe headache and sudden quick onset of diarrhea along with a high fever that lasted from 0730 a.m. to 430 p.m. after 430 p.m. the symptoms rapidly disappeared leaving patient weak and extremely hungry.  after Friday the 15th the only side effect was a sore arm that lasted for a few days.
At the same time, I received my second shingles vaccination in my right arm.  Tentative diagnosis is polymyalgia reumatica .  Extreme bilateral stiffness in upper arms, neck, lower back and hamstrings.  First three covid vaccinations had next to no soreness at injection  site, but this 4th covid and 2nd shingles vaccination caused extremely soreness for a week in both vaccinated arms.  Celebrex only bid 200mg, is current treatment.   Referred to a rheumatologist later this month.  Presently the muscle soreness is increasing daily.
extreme bilateral upper back soreness  affects neck movement  same type of soreness felt on my left upper arm at injection site but on my entire upper back.
Pt with pos edema, pos erythema in posterior side of L arm, Pt stated itching and burning, symptoms began 16Apr07 at 1200.
Information has been received from a physician concerning a 64 year old female with osteoarthritis, hypertension, osteoporosis and hypercholesterolaemia and a history of breast cancer and no allergies who on 23-APR-2007 was vaccinated SC with 0.65 ml dose of Zostavax (Lot # 656609/0015U). On 07-MAY-2007 the patient was presented to office complaining of a "rash" to the right forehead and lateral right eye. It was noted that the patient developed vesicular lesions and pain in right eye and right forehead also associated with herpetic neuralgia one week prior to presenting to the office on approximately 30-APR-2007. The patient was treated with medicines for herpes zoster and was referred to an opthalmologist for further examination. Upon opthalmology examination, the patient was found to have increased eye pressure and viral lesions and was prescribed steroid opthalmic drops. The patient was seen in the office again on 15-MAY-2007 and was doing better. The doctor felt that the patient's experience was a potential threat of blindness. At the time of report the patient was not recovered. The patient's experiences were considered to be other important medical event by the reporter. Additional information has been requested.
Developed right jaw/ear pain within 5 days of first injection, mild headache x 1 day,  without other symptoms, no fever/chills, no sinus pressure or drainage. Morning after 2nd vaccination developed hearing loss right ear. Sensorineural, seen at local urgent care and evaluated on 2/7/2021, no cerumen impaction, no acute otitis.
Fever; chills; fatigue; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old male patient received the unknown dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot number; unknown) via an unspecified route of administration on 26Mar2021 at 12:45 (at the age of 38 years) as single dose for COVID-19 immunisation. Medical history included sleep apnea and COVID-19. The patient did not receive any other medications within 2 weeks of vaccination. The patient had no known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, patient had not tested for COVID-19. On 26Mar2021 at 20:00, patient experienced event fever, chills and fatigue. The patient did not receive any treatment for the adverse event. The clinical outcome of the events fever, chills and fatigue was recovered on an unknown date in Mar2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
11 pm Fever to 101. Tylenol Myalgias Hives on Left arm, then hives on Right arm seen in Emergency Room on 6/7/19 Benadryl 50 mg given. Dx: Mild allergic
Moderate-to-high energy in the first 24hours.  Lethargy accompanied by significant body (joint) aches afterward for approximately 24 hours.  Interesting was that I noticed a 1" stain on my white t-shirt exactly over the injection site 48-72 hours after the injection, as if the vaccine was "oozing" out of the injection site.
Weakness; Fever; Chills; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), PYREXIA (Fever) and CHILLS (Chills) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ASTHENIA (Weakness), PYREXIA (Fever) and CHILLS (Chills). At the time of the report, ASTHENIA (Weakness), PYREXIA (Fever) and CHILLS (Chills) outcome was unknown.            No treatment medication were provided. No concomitant medication were provided. Action taken for Moderna COVID-19 Vaccine was not applicable.   This case was linked to MOD-2021-042439 (Patient Link).
One day later, had low grade fever (not measured) and knot in arm left deltoid where DTaP given. Fever gone with Tylenol. By 5 days post shot, fever was 102 degrees F. 6 days later still high fever (not taken). Parent called health department and was referred to doctor.
4 hours after vaccine, soreness at injection site; severe whole body chills; whole body aches; This is a spontaneous report from a contactable other hcp. A 59-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number and expiry date unknown, intramuscular on the left arm on 07Jan2021 17:45 at a SINGLE DOSE and intramuscular on the left arm on 17Dec2020 18:45 at a SINGLE DOSE for covid-19 immunisation. Medical history was reported as none. Concomitant medication included escitalopram oxalate (LEXAPRO). On 07Jan2021, it was reported that 4 hours after vaccine, there was soreness at injection site. 14 hours following vaccine, the patient experienced sudden onset of severe whole body chills and whole body aches lasting up to 18 hours. The outcome of the events was recovered.   Information on the lot/ batch number has been requested.
Blurry vision, headache, cramps, spotting (bleeding), disorientation, dizzy, nauseous, joint pain, chest pain
Parent reports by phone on 12/12/11 that on 12/09/11 the patient's left arm had and area of redness and swelling that extended 12 inches down the arm. She states she took him to a doctor who told her it was a reaction to the Tdap.
Left upper arm red, round spot. Warm to touch. DTaP given 9/10/02.
Day 1- 1.5 x 1.5cm redness, swollen hard, warm to touch,painful to touch Day- 3x3cm red area, warm to touch, hard center, painful to touch
Patient came in 5 days early for 2nd Pfizer vaccine. Immunizations clinic staff didn't check interval time and that resulted in vaccine being administered 5 days early.
This is the second part of SHINGRIX. I received the vaccine at 5pm approximately, and by 9pm I was having malaise all over my body and my arm hurt. I went to bed and woke up worse. The muscles in my body hurt to the point that I walking a little bit slow. I also felt feverish but did not take temp. I took acetaminophen 500mg by 6:30PM and went to work. At work the pain continue and I felt very cold. I took another acetaminophen 325mg by 10AM. At 1:30PM I left work because I continue to feel body ache, fever and headache. I took acetaminophen 500mg at 2. Now, at 4PM I took my temp and it was 99.2F. Still feeling sick.
Vaccine administered after it was stored at room temperature for 18 hours; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after it was stored at room temperature for 18 hours) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after it was stored at room temperature for 18 hours). On 15-Jun-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after it was stored at room temperature for 18 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were provided by the reporter.
Shingles! Had the usual flu like symptoms for 3-4 days (October 13th-16th) following the immunization.  Low fever & aches. Low grade fever returned 18th, developed small rash on right side of neck afternoon of 10/19, thought maybe it was a bug bite.  Not a lot of pain, just itchy.  Tried cortizone for a few days, then neo-sporin, took Benydryl once, then tried cortizone with antifungal cream.   Rash continued to develop and become more painful.  On 10/24 - Became much more painful and blisters started to develop.  Went to Urgent Care 10/24 in the evening.  Diagnosed as shingles.  Received prescription for anti-viral medicine (Valacyclovir) and starting regiman same evening. Followed up with primary care doctor listed.
Itchy rash appeared 3/20/21. Spread down abdomen, back, legs, arms, up neck. Pt self treated with spray alcohol and oral benadryl.  Went to MD 4/5/21 and received steroid injection. Itchiness has improved.
Received first COVID vaccine 12/18/20. and just had soreness at the site. She received the second dose 1/8/21 and had soreness at site that day. Soreness and redness worsened every day after injection. She began having trouble moving her arm 1/10/21 which continued on 1/11/21. Redness is traveling into axillary region, pain is also in this area now. Went to urgent care at 1:30pm on 1/11/2021.
19JUN97 pt returned to clinic for pre-kindergarten skin test reading & mom requested that RN look @ pt leg where recv vax 17JUN97;had 14 x 11cm area redness & edema;WBC 15.0, EOS 16, tenderness of rt thigh;
Information has been received from a physician concerning a female (demographics not provided) who on unspecified date was vaccinated with her third dose of Gardasil (lot # not provided) and was hospitalized with abdominal pain.  It was reported that the patient also experienced unspecified adverse reactions post her first and second dose of Gardasil.  At the time of this report it was unknown if patient was discharged from the hospital or had recovered from the event.  No other information was provided.  Additional information has been requested.
might be shingles/Blistering rash on right side of body that is  painful and itchy; blistering rash that was painful and itchy; blistering rash that was painful and itchy; This case was reported by a consumer via call center representative and described the occurrence of blistery rash in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2020-2021 season) for prophylaxis.   On 1st September 2020, the patient received the 1st dose of Shingrix (intramuscular) .5 ml and Influenza vaccine Quadrivalent 2020-2021 season (intramuscular). On 3rd September 2020, 2 days after receiving Shingrix and Influenza vaccine Quadrivalent 2020-2021 season, the patient experienced blistery rash, painful rash and itchy rash. On an unknown date, the outcome of the blistery rash, painful rash and itchy rash were not recovered/not resolved.   It was unknown if the reporter considered the blistery rash, painful rash and itchy rash to be related to Shingrix and Influenza vaccine Quadrivalent 2020-2021 season.  Additional details were provided as follows: The patient received Shingrix and flu vaccine in left arm. 2 days later after receiving Shingrix and flu vaccine, the patient experienced a blistering rash that was painful and itchy and was concerned it might be shingles.  Till the time of reporting, the symptoms had not gotten any better.   The reporter did not consent to follow-up.
Headache 5am, hurts to lift head or move neck; Nauseous since 1am; Chills since 1am; All over muscle aches and pains 530 am; Fever 100.4/feeling feverish 6am; Shaking/shivering since 3am
Patient has history of anaphylaxis. Reports dizziness metallic taste in his mouth. also feels that throat is closing in on her and tongue feels big. BP taken and patient monitored. Symptoms worsened regarding swelling of tongue and patient reports it was harder to swallow.  Epi pen given in left lateral  thigh at 0943. Post epinephrine, patient started to feel better. Able to talk better with less discomfort.
This case was reported by a healthcare professional and described the occurrence of hepatitis B antigenemia in a male subject to unspecified age who was vaccinated with TWINRIX for prophylaxis. On an unspecified date the subject received unspecified dose of TWINRIX at 1.0 ml. At an unspecified time after vaccination with TWINRIX, the subject donated blood and tested positive for hepatitis B surface antigen. At the time of reporting the outcome of the event was unspecified. The healthcare professional considered the event was possibly related to vaccination with TWINRIX. Follow-up information received on 13 June 2008 indicated that the subject was 34 years old at the time of the event. The first dose of TWINRIX was administered to the subject on 14 April 2008. On 21 April 2008, the subject tested positive for hepatitis B surface antigen. Other concurrent vaccinations given on 14 April 2008 included Tdap vaccine and TYPHIM Vi, both given intramuscularly. The outcome of the event was unknown at the time of the follow-up and the event was considered possibly related to TWINRIX.
developed rash that the dermatologist diagnosed as eczema; developed Rash; bump as localized swelling; Condition aggravated; Itching; This case was reported by a consumer via call center representative and described the occurrence of eczema in a 81-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix and the 2nd dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix and Shingrix, the patient experienced eczema, rash, mass, condition aggravated and pruritus. On an unknown date, the outcome of the eczema and rash were recovering/resolving and the outcome of the mass, condition aggravated and pruritus were unknown.   It was unknown if the reporter considered the eczema, rash and mass to be related to Shingrix and Shingrix. It was unknown if the reporter considered the condition aggravated and pruritus to be related to Shingrix.  Additional details were provided as follows: The patient developed rash that the dermatologist diagnosed as eczema. It presented after the 1st dose that was administered in either April or May 2019.  It became a little worse after the second dose that was administered in August or September 2019. It was present on the sides of the stomach, feet, the backside of the upper legs and on the left calf. The follow up consent was granted. This case has been linked with case US2020AMR011807, reported by same reporter for same patient. This case US2020011396  was case of recored and US2020AMR011807 would be deleted.
Client reports left arm tingling, left neck pain, "tongue swelling", and left leg soreness.
The day after my vaccine I experienced normal side effects of fatigue and body aches. Later in the afternoon I also started having breathing/asthma issues. My asthma is very controlled and typically I only have flare ups with sickness. The breathing problems I have experienced are very similar to the issues I had when I was sick with Covid-19 in December of 2020.